Market Forecast By Drug Type (Prescription Drugs, OTC Drugs), By Type ( Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Others) And Competitive Landscape
Product Code: ETC036155 | Publication Date: Jun 2023 | Updated Date: Jan 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | Poland Pharmacies and Drug Stores market |
Forecast period | 2025-2031 |
Forecast size | USD 15 Billion by 2024 |
CAGR | 6.9% |
Growing Sector | Healthcare |
The Poland Pharmacies and Drug Stores market report thoroughly covers the market by drug type and by type. The report provides an unbiased and detailed analysis of the on-going market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
In 2024, the Poland Pharmacies and Drug Stores market is valued at approximately $ 10.7 billion, with a projected compound annual growth rate (CAGR) of 6.9% over the next five years. Additionally, by 2030, the market is expected to reach around $ 15 billion. The healthcare sector holds significant position in the overall market.
The Poland pharmacies and drug stores market is a significant segment of the country’s retail and healthcare sectors, characterized by a robust and expanding network of pharmacies, drugstores, and online platforms. The market has been growing steadily due to Poland’s aging population, increasing prevalence of chronic diseases, and rising consumer demand for healthcare products and services. Additionally, the rise of health-conscious consumers, greater access to healthcare services, and the growing trend of self-medication are contributing to the market's expansion. Poland's strong regulatory environment ensures the safe distribution of pharmaceuticals, and the country's well-established pharmacy infrastructure, both in urban and rural areas, plays a crucial role in providing easy access to medications. The rise of e-commerce and digitalization in healthcare is also shaping the future of the market, although challenges
According to 6Wresearch, Poland Pharmacies and Drug Stores market size is projected to grow at a CAGR of 6.9% during 2025-2031. The growth of the Poland pharmacies and drug stores market is driven by several key factors, including the aging population, which increases the demand for medications and healthcare services, and the rising health consciousness among consumers, prompting higher spending on prescription and over-the-counter drugs. Moreover, advancements in digital health solutions and the growth of e-pharmacies are expanding consumer access to medications, fostering market growth. Additionally, the Polish government's increasing investment in the healthcare sector and initiatives to improve public health infrastructure are contributing positively.
However, the Poland Pharmacies and Drug Stores industry faces challenges such as stringent regulatory frameworks that govern drug pricing and distribution, leading to margin pressures for pharmacies. Another challenge is the potential shortage of skilled healthcare professionals, which could affect the capacity of pharmacies to meet demand efficiently. Additionally, the prevalence of counterfeit drugs remains a concern, posing both regulatory and consumer safety risks.
Key companies in the Poland pharmacies and drug stores market include major retail pharmacy chains such as Ziko Apteka, which operates a wide network of pharmacies across the country, and Apteki Gemini, one of the leading pharmacy chains offering both prescription and over-the-counter products. Rossmann Polska and Douglas Polska also play significant roles, offering a wide range of health and beauty products alongside pharmacy services. International companies like CVS Health and Walgreens Boots Alliance have a presence in the market through partnerships and acquisitions, expanding their footprint. Other important players include Polpharma, a leading pharmaceutical manufacturer in Poland, which supplies both domestic and international markets.
The Poland pharmacies and drug stores market is heavily regulated to ensure the safety, efficacy, and accessibility of pharmaceutical products. The Ministry of Health is responsible for overseeing the regulatory framework, with regulations stemming from both national and European Union laws. All pharmacies must be licensed, and only qualified professionals, such as pharmacists, can operate them. The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products regulates the approval and distribution of medicines, ensuring compliance with safety and quality standards. Prescription drugs can only be dispensed with a valid prescription, and their pricing is controlled under a reimbursement system, with price caps applied to certain medications.
Additionally, the Polish National Health Fund (NFZ) plays a role in reimbursing healthcare services, including the distribution of certain pharmaceuticals. Further, these initiatives have further boosted the Poland Pharmacies and Drug Stores market revenues. Furthermore, the e-pharmacy sector is also regulated, with strict rules governing the sale of medicines online to protect consumers from counterfeit products. These regulations ensure that pharmaceuticals are provided in a manner that prioritizes patient safety and access while maintaining the integrity of the market.
The Poland pharmacies and drug stores market is poised for steady growth in the coming years, driven by increasing healthcare needs, an aging population, and growing awareness of health and wellness. The rise of e-pharmacy services, spurred by digital transformation, is expected to play a significant role in expanding access to pharmaceuticals, particularly for individuals in remote or underserved areas. Additionally, the growing trend of self-medication and the increasing demand for over-the-counter products will continue to shape the market's evolution.
However, challenges such as rising healthcare costs and regulatory pressures on pricing and reimbursement models could impact profit margins for pharmacies. The expansion of telemedicine and digital health services, coupled with innovative drug delivery methods like home delivery and personalized medicine, presents opportunities for pharmacies to diversify their services.
According to Ravi Bhandari, Research Head, 6Wresearch, the prescription drugs category in Poland's pharmacies and drug stores market is expected to experience significant growth, driven by an aging population, rising incidences of chronic diseases, and advancements in healthcare treatments. As the demand for specialized therapies, including biologics and personalized medicines, increases, pharmacies will play a crucial role in providing access to these essential medications. Additionally, the ongoing development of e-prescriptions and digital health technologies is anticipated to further streamline the distribution process, making prescription drugs more accessible and convenient for patients. With a stronger focus on preventative care and early diagnosis, the prescription drugs market is poised for continued expansion, particularly in high-demand therapeutic areas such as oncology, cardiology, and neurology.
The hospital pharmacy segment in Poland's pharmacies and drug stores market is set to grow steadily, fueled by the increasing complexity of healthcare needs and the rising demand for specialized medications. As hospitals expand their services and integrate more advanced treatments, the role of hospital pharmacies becomes even more critical in ensuring the proper management of medications, particularly in areas like oncology, surgery, and critical care. With a greater emphasis on personalized medicine and the management of chronic diseases, hospital pharmacies are expected to diversify their offerings to include biologics, immunotherapies, and highly specialized drug regimens. Additionally, the integration of hospital pharmacies with digital health systems and electronic medical records is expected to enhance operational efficiencies, improving patient outcomes and medication safety.
The Poland Pharmacies and Drug Stores market report provides a detailed analysis of the following market segments -
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Pharmacies and Drug Stores Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Pharmacies and Drug Stores Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Pharmacies and Drug Stores Market - Industry Life Cycle |
3.4 Poland Pharmacies and Drug Stores Market - Porter's Five Forces |
3.5 Poland Pharmacies and Drug Stores Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Poland Pharmacies and Drug Stores Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Poland Pharmacies and Drug Stores Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Poland Pharmacies and Drug Stores Market Trends |
6 Poland Pharmacies and Drug Stores Market, By Types |
6.1 Poland Pharmacies and Drug Stores Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Drug Type, 2021-2031F |
6.1.3 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Prescription Drugs, 2021-2031F |
6.1.4 Poland Pharmacies and Drug Stores Market Revenues & Volume, By OTC Drugs, 2021-2031F |
6.2 Poland Pharmacies and Drug Stores Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Community Pharmacy, 2021-2031F |
6.2.3 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.4 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Clinical Pharmacy, 2021-2031F |
6.2.5 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Industrial Pharmacy, 2021-2031F |
6.2.6 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Compounding Pharmacy, 2021-2031F |
6.2.7 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Consulting Pharmacy, 2021-2031F |
6.2.8 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2021-2031F |
6.2.9 Poland Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2021-2031F |
7 Poland Pharmacies and Drug Stores Market Import-Export Trade Statistics |
7.1 Poland Pharmacies and Drug Stores Market Export to Major Countries |
7.2 Poland Pharmacies and Drug Stores Market Imports from Major Countries |
8 Poland Pharmacies and Drug Stores Market Key Performance Indicators |
9 Poland Pharmacies and Drug Stores Market - Opportunity Assessment |
9.1 Poland Pharmacies and Drug Stores Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Poland Pharmacies and Drug Stores Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Poland Pharmacies and Drug Stores Market - Competitive Landscape |
10.1 Poland Pharmacies and Drug Stores Market Revenue Share, By Companies, 2024 |
10.2 Poland Pharmacies and Drug Stores Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |